E(1F&k2G(1F&l1H&n11WdLetterhead&l7C&a200CType=%(Type)s;npat=%(npat)s;nSS=%(nSS)s   ;nmob=%(nmob)s    ;tel=%(nmob)s    ;cmed=%(cmed)s;suf=          ;
&a200Cpfx=%(pfx)s  ;pnom=%(pnom)s             ;prn=%(prn)s            ;ad1=%(ad1)s                     ;datedos=%(datedos)s;
&a200Cad2=%(ad2)s                         ;ad3=                                        ;numdos=%(numdos)s ;ddn=%(ddn)s;
&a200Cnommed=%(nommed)s                       ;ccor=        ;nomcor=                                        ;age=%(age)s  ;
&a200Ctdu=       ;cprl=%(cprl)s     ;nprl=%(nprl)s               ;tprl=                ;
&a-5R(s0p10h12v0s0b3T(1F                                            %(numdos)s (s0p16h8.v0s0b3T(1F -%(datedos)s-          -p1/1  (s0p10h12v0s0b3T(1F 





&a12R                                  
                                          %(pfx)s   %(pnom)s %(prn)s         
                                          NJF:                    
                                          %(ad1)s                     
  %(nommed)s                       %(ad2)s                         
  50 Rue Pierre Charron                   
  75008 PARIS                             
                                                 Besan\on, le%(datedos)s @13H31
  Dossier N[%(numdos)s du(s0p10h12v0s3b3T(1F %(datedos)s                                         (s0p10h12v0s0b3T(1F 


    (s1p16v0s4101T(1F                                           B I O C H I M I E       (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1F                              (Analyseur VITROS 250 -ORTHO-CLINICAL DIAGNOSTICS)        (s0p10h12v0s0b3T(1F
                                                         (s0p16h8.v0s0b3T(1F  R{f{rence           Ant{rieurs        (s0p10h12v0s0b3T(1F
                                                                        (s0p16h8.v0s0b3T(1F10/02/14 (s0p10h12v0s0b3T(1F
   GLYCEMIE A JEUN. . . . . . . .       1,57 g/l       (s0p16h8.v0s0b3T(1F   0,80 @ 1,10    (s0p10h12v0s0b3T(1F      (s0p16h8.v0s0b3T(1F   3,01 (s0p10h12v0s0b3T(1F
                                        8,71 mmol/l    (s0p16h8.v0s0b3T(1F   4,44 @ 6,11    (s0p10h12v0s0b3T(1F
    (s0p16h8.v0s0b3T(1FTechnique colorim{trique (s0p10h12v0s0b3T(1F

   (s0p10h12v0s3b3T(1FCrit}res du diab}te (ADA,OMS)                                               (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1FTol{rance glucidique normale:@ jeun :< 1,10 g/l post-charge(2h-75g):< 1,%(cprl)s g/l          (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1FHyperglyc{mie mod{r{e       :@ jeun : 1,10 -1,25 g/l                                    (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1FIntol{rance au glucose      :@ jeun :< 1,26 g/l post-charge(2h-75g):1,4-1,99 g/l        (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1FDiab}te                     :@ jeun :>=1,26 g/l post-charge(2h-75g):> 2,00 g/l          (s0p10h12v0s0b3T(1F

                                                                        (s0p16h8.v0s0b3T(1F10/02/14 (s0p10h12v0s0b3T(1F
   HEMOGLOBINE A1c  . . . . . . .       7,%(cprl)s %         (s0p16h8.v0s0b3T(1F                  (s0p10h12v0s0b3T(1F      (s0p16h8.v0s0b3T(1F  10,60 (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1F(*)Technique HPLC avec chromatographe HA 81%(cprl)s de MENARINI)                              (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1FObjectifs de r{f{rence pour la valeur de l'HbA1c (Normes NGSP-DCCT) uniquement          (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1Fdans le suivi de l'{quilibre glyc{mique :                                               (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1F  4 - 6 %   :    Sujet normal            6 - 7 %  :   Diab{tique bien {quilibr{         (s0p10h12v0s0b3T(1F
   (s0p16h8.v0s0b3T(1F  7 - 8 %   :    Diab{tique @ surveiller                                                (s0p10h12v0s0b3T(1F


    (s1p16v0s4101T(1F                         CHIMIE DES URINES  (sur {chantillon)      (s0p10h12v0s0b3T(1F

   GLYCOSURIE . . . . . . . . . .    Absence

   ACETONE. . . . . . . . . . . .    Absence
(s0p16h8.v0s0b3T(1F (s0p10h12v0s0b3T(1F     
                                           &a69R&a58C(s0p16h8.v0s0b3T(1F r{sultats RECTOVERSO(s0p10h12v0s0b3T(1F 
&a71R&a10C(s0p16h8.v0s0b3T(1F (s0p10h12v0s0b3T(1F &a71R&a33.5C(s0p16h8.v0s0b3T(1F Biologiste M{dical(s0p10h12v0s0b3T(1F &a71R&a61C(s0p16h8.v0s0b3T(1F J.ALMARCHA(s0p10h12v0s0b3T(1F               &a200Cff##